Adherence to National Comprehensive Cancer Network® Guidelines for Testicular Cancer

Kevin M Wymer1, Shane M Pearce2, Kelly T Harris3

  • 1Pritzker School of Medicine, University of Chicago, Chicago, Illinois.

The Journal of Urology
|September 25, 2016
PubMed
Abstract

Insights

Testicular cancer management errors, including inappropriate imaging and overtreatment, are common. This non-guideline directed care significantly increases relapse risk in young men.

Area of Science:

  • Oncology
  • Urology
  • Clinical Management

Background:

  • Testicular cancer is the most common malignancy in young men.
  • Established treatment guidelines aim to optimize patient outcomes.
  • Variations in care can impact treatment efficacy and patient morbidity.

Purpose of the Study:

  • To characterize errors in testicular cancer management.
  • To identify the frequency and types of non-guideline directed care.
  • To assess the impact of non-guideline directed care on relapse-free survival.

Main Methods:

  • Retrospective review of 593 testicular cancer patients from 3 US academic centers (2007-2016).
  • Defined non-guideline directed care based on National Comprehensive Care Network guidelines.
  • Used multivariable logistic and Cox regression to analyze predictors and outcomes.

Main Results:

  • Non-guideline directed care was observed in 30% of patients (177/593).
  • Most common errors included inappropriate imaging (44%) and overtreatment (40%).
  • Non-guideline directed care significantly predicted relapse (HR 2.49, p <0.01).

Conclusions:

  • Non-guideline directed care in testicular cancer is prevalent.
  • Inappropriate imaging and overtreatment are frequent management deviations.
  • Deviations from guidelines lead to delayed therapy, increased morbidity, and higher relapse rates.